Analytical Data
-
基因名
VSTM2L
- Application
-
别名
C20orf102; dJ1118M15.2; Uncharacterized protein C20orf102 precursor; V set and transmembrane domain containing 2 like; V set and transmembrane domain containing protein 2 like protein; V-set and transmembrane domain-containing protein 2-like protein; VSTM 2L; Vstm2l; VTM2L_HUMAN
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96N03
-
表达区间
25-204aa
-
分子量
36 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VSTM2L, or V-set and transmembrane domain-containing 2-like protein, has garnered attention in recent years due to its potential roles in immune regulation and cell signaling. Researchers have identified VSTM2L as a member of the V-set immunoglobulin superfamily, which is known for its involvement in various biological processes, including cell adhesion, recognition, and immune responses. Initial studies suggest that VSTM2L may play a role in modulating inflammatory responses and could be implicated in the pathogenesis of autoimmune diseases. The protein's expression patterns, particularly in immune cells, hint at its significance in maintaining immune homeostasis. However, the functional mechanisms underlying VSTM2L's actions remain largely unexplored, leading to a growing interest in delineating its structure, function, and potential therapeutic applications. The recombinant production of VSTM2L protein will enable further investigation into its biological functions, interactions with other molecules, and potential as a biomarker or therapeutic target. Understanding VSTM2L's role in the immune system could pave the way for novel strategies in treating inflammatory diseases and enhancing immune responses in clinical settings. As such, research into VSTM2L and its recombinant protein forms is essential for advancing our knowledge of immune regulation and developing innovative therapeutic approaches.
